Terminated
Open-Label Phase 2 Trial of a Steroid-Free, CNI-Free, Belatacept-Based Immunosuppressive Regimen
NCT01856257
- Conditions
- Kidney Transplantation, Primary Renal Allograft Candidate
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- University of California, San Francisco San Francisco, California, United States
- Emory University Atlanta, Georgia, United States